doi: 10.1136/pgmj.49.570.265.
The treatment of jaundice due to liver metastases by quadruple chemotherapy
- PMID: 4760722
- PMCID: PMC2495694
- DOI: 10.1136/pgmj.49.570.265
Item in Clipboard
The treatment of jaundice due to liver metastases by quadruple chemotherapy
Postgrad Med J.
1973 Apr.
Abstract
This is a report of seven patients with jaundice due to extensive hepatic secondary deposits, who were treated with combination chemotherapy.
In six cases the jaundice was relieved and biochemical and liver function tests improved.
Three patients survived for 1 year or longer.
Similar articles
-
Results of 27 cases with hepatic metastases treated by combination chemotherapy.Br J Cancer. 1972 Dec;26(6):466-72. doi: 10.1038/bjc.1972.64. Br J Cancer. 1972. PMID: 4647397 Free PMC article.
-
Treatment of hepatic metastases from breast cancer.Clin Oncol. 1978 Jun;4(2):167-71. Clin Oncol. 1978. PMID: 668248 No abstract available.
-
Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.Prog Clin Biol Res. 1977;12:459-66. Prog Clin Biol Res. 1977. PMID: 335404 Clinical Trial. No abstract available.
-
[Chemotherapy of prostatic cancer].Vopr Onkol. 1985;31(9):3-12. Vopr Onkol. 1985. PMID: 2931901 Review. Russian. No abstract available.
-
Therapeutic approaches to hepatoma.Cancer Treat Rev. 1975 Mar;2(1):73-6. doi: 10.1016/s0305-7372(75)80016-8. Cancer Treat Rev. 1975. PMID: 171068 Review. No abstract available.
